Recent research has raised alarms regarding Wegovy, a widely used weight-loss medication. Scientists examining millions of FDA safety reports discovered a potential connection between Wegovy and a rare ailment called ischemic optic neuropathy, often referred to as an 'eye stroke.' This condition arises when blood supply to the optic nerve suddenly decreases, which could lead to blurred vision, blind spots, or even irreversible vision impairment.
Although the study does not establish a direct causation between Wegovy and vision impairment, the correlation appears more pronounced than with other similar drugs like Ozempic. Experts emphasize the importance of further research as the usage of GLP-1 weight-loss medications continues to rise globally.
These drugs have aided countless individuals in shedding pounds and enhancing metabolic health. However, with their increasing popularity, researchers are focusing more on infrequent but serious side effects.
It's crucial to stay informed and consult with a healthcare provider regarding any concerns when taking prescription medications.
